Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Limoneira | LMNR | 2. avr 2025 | 17.88 | +0.85 |
Lincoln Educational Services | LINC | 2. avr 2025 | 16.64 | +2.97 |
Lincoln Electric | LECO | 2. avr 2025 | 194.78 | +1.33 |
Lincoln National | LNC | 2. avr 2025 | 37.27 | +3.50 |
Lincoln National Pref | LNC-D | 2. avr 2025 | 26.71 | +0.15 |
Lindblad Expeditions | LIND | 2. avr 2025 | 9.57 | -0.10 |
Linde | LIN | 2. avr 2025 | 469.74 | +0.57 |
Lindsay | LNN | 2. avr 2025 | 130.45 | +2.24 |
Lineage | LINE | 2. avr 2025 | 58.53 | +2.85 |
Lineage Cell Therapeutics | LCTX | 2. avr 2025 | 0.44 | +6.37 |
Linkage Global A | LGCB | 2. avr 2025 | 0.16 | -1.48 |
Linkbancorp | LNKB | 2. avr 2025 | 7.17 | +6.22 |
Linkers Industries | LNKS | 2. avr 2025 | 0.57 | +12.50 |
Lion ADR | LGHL | 2. avr 2025 | 3.50 | +9.38 |
Lionheart Units | CUBWU | 2. avr 2025 | 10.29 | 0.00 |
Lions Gate Entertainment A | LGF-A | 2. avr 2025 | 8.87 | +2.78 |
Lions Gate Entertainment B | LGF-B | 2. avr 2025 | 7.95 | +2.98 |
Lipella Pharmaceuticals | LIPO | 2. avr 2025 | 2.58 | +0.39 |
Lipocine | LPCN | 2. avr 2025 | 3.17 | -5.23 |
LiqTech International | LIQT | 2. avr 2025 | 1.63 | +1.24 |
Liquidia | LQDA | 2. avr 2025 | 14.52 | +0.07 |
Liquidity Services | LQDT | 2. avr 2025 | 31.66 | +0.32 |
Lisata Therapeutics | LSTA | 2. avr 2025 | 2.07 | -4.17 |
Lithia Motors | LAD | 2. avr 2025 | 306.12 | +3.13 |
Lithium Americas | LAC | 2. avr 2025 | 2.76 | 0.00 |
Lithium Argentina AG | LAR | 2. avr 2025 | 2.14 | 0.00 |
Littelfuse | LFUS | 2. avr 2025 | 196.63 | +1.83 |
LivaNova | LIVN | 2. avr 2025 | 39.50 | +1.20 |
Live Nation Entertainment | LYV | 2. avr 2025 | 134.65 | +2.00 |
Live Oak Acquisition Corp. V - Units | LOKVU | 2. avr 2025 | 10.08 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.